Skip to main content
. 2021 Mar 5;17(1):e1141. doi: 10.1002/cl2.1141

Table 1.

Effect of probiotic supplementation during neonatal period: Subgroup analysis

Outcome or subgroup No. of studies Effect estimate: relative risk Test for subgroup difference
All‐cause mortality: subgroup analysis: settings
Hospital based 22 0.78 [0.65, 0.94] p = .31
Community based 3 1.25 [0.51, 3.05] I 2 = 0%
All‐cause mortality: subgroup analysis: type of probiotics
Preparation contain a single strain of probiotics 9 0.80 [0.61, 1.05] p = .95
Preparation contained multiple strains of probiotics 12 0.80 [0.58, 1.09] I 2 = 0%
Preparation contained synbiotics (prebiotics + probiotics) 5 0.69 [0.29, 1.61]
All‐cause mortality: subgroup analysis: type of participants
Study include preterm/low birth weight babies 24 0.79 [0.65, 0.95] p = .47
Study included term infants only 1 1.38 [0.31, 6.08] I 2 = 0%
All‐cause mortality: subgroup analysis: type of feedings
Baby received breastmilk only 14 0.81 [0.62, 1.05] p = .44
Baby received formula milk only 1 1.38 [0.31, 6.08]
Baby received both both breastmilk and formula milk 8 0.69 [0.48, 0.99] I 2 = 0%
Type of feeding was unclear 3 1.33 [0.63, 2.81]
All‐cause mortality: subgroup analysis: probiotics preparation
Preparation contained Lactobacillus 10 0.82 [0.63, 1.05] p = .47
Preparation contained Bifidobacterium 1 0.43 [0.17, 1.09]
Preparation contained both Lactobacillus and Bifidobacterium 13 0.71 [0.47, 1.08] I 2 = 0%
Preparation contained Saccharomyces boulardii only 2 1.12 [0.46, 2.71]
Necrotizing enterocolitis: subgroup analysis: probiotic preparation
Preparation contained Lactobacillus 13 0.39 [0.25, 0.61] p = .05
Preparation contained Bifidobacterium 1 0.20 [0.09, 0.47]
Preparation contained both Lactobacillus and Bifidobacterium 14 0.49 [0.36, 0.68]
I 2 = 60.5%
Preparation contained S. boulardii only 2 0.94 [0.45, 1.95]
Necrotizing enterocolitis: subgroup analysis: type of feeding
Baby received breastmilk only 13 0.43 [0.31, 0.59] p = .74
Baby received formula only 1 0.21 [0.03, 1.76]
Baby received both breastmilk and formula milk 9 0.55 [0.33, 0.92] I 2 = 0%
Type of feeding was unclear 7 0.41 [0.17, 1.00]
Necrotizing enterocolitis: subgroup analysis: type of probiotics
Preparation contained a single strain of probiotics 12 0.48 [0.30, 0.76] p= .50
Preparation contained multiple strains of probiotics 15 0.48 [0.35, 0.67] I 2 = 0%
Preparation contained synbiotics (prebiotics + probiotics) 3 0.28 [0.12, 0.67]
Neonatal sepsis: subgroup analysis: probiotic preparation
Preparation contained Lactobacillus 11 0.74 [0.62, 0.87] p = .79
Preparation contained Bifidobacterium 1 0.81 [0.60, 1.09]
Preparation contained both Bifidobacterium and Lactobacillus 6 0.83 [0.68, 1.02] I 2 = 0%
Preparation contained S. boulardii only 3 0.73 [0.57, 0.94]
Neonatal sepsis: subgroup analysis: type of feeding
Baby received breastmilk only 8 0.71 [0.61, 0.83] p = .04
Baby received formula milk only 2 0.59 [0.22, 1.56]
Baby received both formula and breastmilk only 6 0.77 [0.65, 0.90] I 2 = 65%
Type of feeding was unclear 4 0.95 [0.82, 1.09]
Neonatal sepsis: type of probiotics
Preparation contained single strain of probiotics 8 0.84 [0.74, 0.96] p = .21
Preparation contained multiple strains of probiotics 9 0.81 [0.68, 0.97]
I 2 = 35%
Preparation contained synbiotics (prebiotics + probiotics) 4 0.67 [0.54, 0.83]
Neonatal sepsis: subgroup analysis: settings
Hospital based 19 0.83 [0.76, 0.91] p = .19
Community based 2 0.67 [0.49, 0.91] I 2 = 42%